RecruitingNCT06562608
Studying brain and thinking changes when anticholinergic medicines are stopped or continued
About this title
Read the official source — NCT06562608Medication studyAges 40–70United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 40 years to 70 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 105
- Sponsor
- Deepak K. Sarpal, M.D.
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 40 Years to 70 Years
- Official registry ID
- NCT06562608
- Official title
Show the full official title
Neural Mechanisms of Anticholinergic Burden in Mid- to Late-Life Schizophrenia Spectrum
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Pittsburgh
Questions about this study
Who is behind this study?
The study sponsor is Deepak K. Sarpal, M.D.
Does this study involve medication?
Yes. The study involves medication, including Anticholinergic Deprescription and No Anticholinergic Deprescription.
Who can participate?
Listed age limits: 40 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
